PIL against 10 top pharma Cos in SC alleging sale of Remdesivir and Favipiravir without valid license Ruchika Sharma7 Sept 2020 1:26 PM ISTIt has also made 10 pharmaceutical companies, including Cipla Ltd, Dr Reddy's Laboratories Ltd, Hetero Labs Ltd and Zydus Cadila Healthcare Ltd,...
COVID Vaccine: Bharat Biotech gets CDSCO nod to conduct Phase II Trials MD Bureau7 Sept 2020 11:30 AM ISTThese trials of BBV152 coronavirus vaccine or Covaxin will be conducted on 380 participants, who will have to be screened for 4 days after they...
DCGI green flag to Abbott heart failure, angina treatment drug Ivabradine Farhat Nasim3 Sept 2020 4:54 PM ISTAbbott plans to launch Ivabradine prolonged-release tablets in the Indian market in the coming weeks.
CDSCO Declares 35 Drug Samples Including Paracetamol, Hand Sanitizers As Not Of Standard Quality Farhat Nasim30 Aug 2020 11:30 AM ISTNew Delhi: The apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 35 drug samples and sanitizers as 'Not of...
Bharat Biotech gets CDSCO green flag to conduct Covaxin trial via Intradermal route Farhat Nasim24 Aug 2020 2:19 PM ISTNew Delhi: In a major advancement, Hyderabad-based drugmaker Bharat Biotech has secured permission from Central Drugs Standard Control Organisation...
DCGI slams drugmaker Digital Vision over contaminated Cofset AT syrup, issues stop-sale order Farhat Nasim11 Aug 2020 1:27 PM ISTNew Delhi: In a major setback to Himachal Pradesh-based drug maker Digital Vision, the Drugs Controller General of India (DCGI) has directed all state...
DCGI approves list of 471 FDCs of vitamin, mineral, micronutrient; asks manufacturers to get licence Farhat Nasim5 Aug 2020 4:32 PM ISTNew Delhi: Through a recent letter, the Drugs controller general of India (DCGI) has released a list of 471 new fixed-dose combinations (FDCs) related...
CDSCO panel recommends Serum Institute of India for phase 2, 3 human clinical trials of Oxford vaccine candidate Ruchika Sharma1 Aug 2020 11:55 AM ISTNew Delhi: A subject expert committee on COVID-19 on Friday recommended to the country's drug regulator that permission be granted to Serum Institute...
DCGI asks Serum Institute to revise protocol for phase 2, 3 trials of Oxford COVID-19 vaccine Ruchika Sharma30 July 2020 3:11 PM ISTNew Delhi: A CDSCO expert panel has sought clarifications from Serum Institute of India (SII) over its application to the Drugs Controller General of...
Biocon to furnish more data for consideration of Itolizumab in treating COVID patients Farhat Nasim29 July 2020 4:24 PM ISTBengaluru: After facing rejection from the Health Ministry, Bengaluru-based drugmaker Biocon is now preparing to present 'more data' for consideration...
Avra Labs secures CDSCO nod to manufacture, market Favipiravir API Ruchika Sharma28 July 2020 12:11 PM ISTHyderabad: Avra Laboratories Pvt Ltd, a city based pharma company, has been granted regulatory approval by the Central Drugs Standard Control...
Setback to Biocon: Health Ministry Says NO To Psoriasis Drug Itolizumab In Clinical Management Protocols For COVID-19 Ruchika Sharma27 July 2020 3:59 PM ISTNew Delhi: In a major setback to drug major, Biocon, the National Task Force on COVID-19 has decided against including Itolizumab drug in clinical...
